Door Closes, Window Opens For Generic-Drug Injury Claims
Though its ruling on Monday stamped out one remaining glimmer of hope for plaintiffs looking to hold generic-drug makers liable for their injuries, the U.S. Supreme Court appears to have created...To view the full article, register now.
Already a subscriber? Click here to view full article